Login

Dova Pharmaceuticals Inc. SEC Filings

Filed On Filing
22 Nov 2019 FORM 15
18 Nov 2019 EFFECT
18 Nov 2019 AMENDMENT NO. 4 TO SCHEDULE 13G
15 Nov 2019 Form 4: Perceptive Advisors Llc, 10% owner and 2 others

Disposed of 3,125,851 shares (Other Transaction)

12 Nov 2019 Form 4: Zaccardelli David, Director

Returned 76,647 shares to the issuer · Disposed of 1,000,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Wysenski Nancy, Director

Returned 6,274 shares to the issuer · Disposed of 10,000 Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Stalfort Sean, Director

Disposed of 635,665 shares (Tender Offer) ($17.5M)

12 Nov 2019 Form 4: Novak Alfred J, Director

Returned 6,901 shares to the issuer · Disposed of 43,000 Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Manning Paul B, Director

Disposed of 14,762,242 shares (Tender Offer) ($406M)

12 Nov 2019 Form 4: Laliberte Kevin, Sr. VP, Product Development

Returned 4,761 shares to the issuer · Disposed of 200,250 Employee Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Jeffs Roger, Director

Returned 66,993 shares to the issuer · Disposed of 43,000 Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Hoitt Jason, Chief Commercial Officer

Returned 9,970 shares to the issuer · Disposed of 250,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Hahn Mark W, Chief Financial Officer

Returned 9,024 shares to the issuer · Disposed of 300,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Goldman Steven M., Director

Returned 149,280 shares to the issuer · Disposed of 18,416 Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 Form 4: Allen Lee F Md PhD, Chief Medical Officer

Returned 9,635 shares to the issuer · Disposed of 261,466 Employee Stock Option (Right to Buy) (Disposition to Issuer)

12 Nov 2019 25-NSE
12 Nov 2019 AMENDMENT NO. 1
12 Nov 2019 AMENDMENT NO. 1
12 Nov 2019 AMENDMENT NO. 1
12 Nov 2019 AMENDMENT NO. 2

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support